Taylor Morrison Reports Weaker Q4 & FY25 Results, Lowers 2026 Guidance, but Boosts Share Buyback to $1B
Summary
Taylor Morrison reported weaker Q4 and full-year 2025 financial results and provided lower guidance for 2026, but also announced a significant increase to its share repurchase program.
Key Events
-
Q4 and Full Year 2025 Financial Performance
Reported declines in net income, home closings revenue, and gross margins for both the fourth quarter and full year 2025.
-
Significant Backlog Reduction
Sales order backlog decreased by over 40% year-over-year, indicating future revenue challenges.
-
Lowered 2026 Outlook
Provided guidance for fewer home closings and lower average prices in 2026 compared to 2025.
-
Expanded Share Repurchase Program
Board authorized an additional $1 billion for common stock repurchases, replacing the prior program and signaling a strong commitment to shareholder returns.
Analysis
The filing presents a mixed picture for Taylor Morrison Home Corporation. The company reported a notable decline in fourth-quarter and full-year 2025 financial results, including reduced net income, home closings revenue, and gross margins. Furthermore, the company issued a weaker outlook for 2026, anticipating decreases in home closings and average prices, alongside a significant 40% year-over-year reduction in its sales order backlog. These operational headwinds are partially offset by a substantial capital allocation decision: the Board's authorization of an additional $1 billion for share repurchases, representing approximately 15% of the current market capitalization. This signals a strong commitment to returning capital to shareholders and could provide support for the stock amidst challenging market conditions. Investors will need to weigh the deteriorating operational environment and reduced forward guidance against the significant shareholder return initiative.
At the time of this filing, TMHC was trading at $67.68 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $6.5B. The 52-week trading range was $51.90 to $72.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.